Brief: Eurobio Scientific H1 EBITDA Down At Eur 26.0 Million

Eurobio Scientific SA

11/10/2022 07:42

Oct 11 (Reuters) - Eurobio Scientific SA  ALERS.PA :
    * H1 EBITDA EUR  26.0 MILLION VERSUS EUR 42.5 MILLION YEAR
AGO
    * EUROBIO SCIENTIFIC SA - H1 NET PROFIT EUR 19.2 MILLION
VERSUS
EUR 33.1 MILLION YEAR AGO
    * OUTLOOK: HISTORICAL BUSINESS IS EXPECTED TO GROW STEADILY,
WITH
HIGHER MARGINS DUE TO THE INCREASE IN THE SHARE OF PROPRIETARY
PRODUCTS AND THE REALLOCATION OF THE DISTRIBUTION PORTFOLIO
    * H1 TOTAL OPERATING INCOME EUR 84.3 MILLION VERSUS EUR 95.6
MILLION YEAR AGO
    * TOTAL CASH AND CASH EQUIVALENTS THUS AMOUNTED TO €111.2
MILLION
AT JUNE 30, 2022 AND SHAREHOLDERS' EQUITY TO €168.6 MILLION
    * FINANCIAL DEBT DECREASED AGAIN, TO €8.8 MILLION COMPARED
TO
€10.7 MILLION AT 31/12/21
    * END-H1 CASH FLOW FROM ACTIVITY EUR 25.5 MILLION VERSUS EUR
29.9
MILLION YEAR AGO

Source text for Eikon:  ID:nGNE9y2kzf 
Further company coverage:  ALERS.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))